Oxbridge Re Holdings Limited (OXBR)
Oxbridge Re Holdings Limited (OXBR) is a specialty reinsurance company that provides innovative insurance solutions primarily focused on catastrophe, alternative risk transfer, and niche markets. Established as a Bermuda-based company, Oxbridge Re emphasizes analytical approaches and advanced modeling to deliver tailored reinsurance products to its clients.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 30, 2017 | $0.12 | 2017-09-21 | 2017-09-23 |
| June 30, 2017 | $0.12 | 2017-06-21 | 2017-06-23 |
| March 30, 2017 | $0.12 | 2017-03-15 | 2017-03-17 |
| December 30, 2016 | $0.12 | 2016-12-21 | 2016-12-23 |
| September 30, 2016 | $0.12 | 2016-09-21 | 2016-09-23 |
Dividends Summary
- Oxbridge Re Holdings Limited has issued 13 dividend payments over the past 3 years
- The most recent dividend was paid 2912 days ago, on September 30, 2017
- The highest dividend payed out to investors during this period was $0.12 per share
- The average dividend paid during this period was $0.12 per share.
Company News
Oxbridge Re Holdings Limited will host a conference call on August 14, 2025 at 4:30 p.m. Eastern time to discuss second quarter 2025 financial results, with details provided for call-in and replay options.
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period. Anavex Life Sciences shares fell 10% to $6.35 on Monday. Here are some other stocks moving in today's mid-day session. Gainers RedHill Biopharma Ltd. (NASDAQ: RDHL) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years' market exclusivity for Talicia. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone. Tharimmune, Inc. (NASDAQ: THAR) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis. Asset Entities Inc. (NASDAQ: ASST) gained 34% to $0.4703 after the company announced a stock repurchase program. Captivision Inc. (NASDAQ: CAPT) rose 20.1% to $2.81 after surging 44% on Friday. Perfect Corp. (NYSE: PERF) climbed 19.7% to $2.9944. The company on Monday announced ...